Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Journey of the Human Papillomavirus (HPV) in a Developing Country over 5 Years (2010 - 2015)

  • Danial, M (Clinical Research Center, Hospital Pulau Pinang) ;
  • Sivasangari, S (Clinical Research Center, Hospital Pulau Pinang) ;
  • Arulappen, AL (Pharmacy Department, Hospital Pulau Pinang) ;
  • Ong, LM (Clinical Research Center, Hospital Pulau Pinang)
  • Published : 2016.04.11
Download PDF
⟨ Previous Next ⟩

Abstract

Human papillomavirus (HPV) is a prevalent sexually transmitted infection with serious medical, sexual, and relationship consequences. HPV vaccine protection is available globally but unfortunately vaccine uptake is inconsistent everywhere. From this study, it was observed that the awareness of cervical cancer, HPV virus and HPV vaccination in Malaysia is high, at 83.1%, 73.9% and 73.3% of respondents, respectively. However, a considerably low percentage had undergone HPV vaccination (8.6%) compared to those who had experienced a Pap smear (32.9%). Awareness between cervical cancer and HPV virus and vaccination was low. Health care providers and the governing bodies have to play a vital role in disseminating holistic information on the vaccine and the importance of getting vaccinated to the public more vigorously in Malaysia.

Keywords

References

  1. Al-Dubai SAR, Alshagga MA, Al-Naggar RA, et al (2010). Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev, 11, 887-92.
  2. Brewer N, Fazekas K (2007). Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med, 45, 107-14. https://doi.org/10.1016/j.ypmed.2007.05.013
  3. Calloway C, Jorgensen CM, Saraiya M, et al (2006). A content analysis of news coverage of the HPV vaccine by the US newspaper. J Womens Health, 15, 803-9. https://doi.org/10.1089/jwh.2006.15.803
  4. Cheah P (1994). Human papillomavirus related diseases in Malaysians. Malaysian J Pathol, 16, 15-7.
  5. Christian WJ, Christian A, Hopenhayn C (2009). Acceptance of the HPV vaccine for adolescent girls: Analysis of the state-added questions from the BRFSS. J Adolescent Health, 44, 437-45. https://doi.org/10.1016/j.jadohealth.2008.09.001
  6. Faridi R, Zahra A, Khan K, et al (2011). Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J, 8, 269. https://doi.org/10.1186/1743-422X-8-269
  7. Gloria YH, Studentsov Y, Bierman R, et al (2004). Natural history of human papillomavirus type 16 virus like particle antibodies in young women. cancer epidemiology, Biomarkers Prev, 13, 110-6. https://doi.org/10.1158/1055-9965.EPI-03-0191
  8. Goncalves AK, Cobucci RN, Rodrigues HM, et al (2014). Safety, tolerability and side effects of human papillomavirus vaccines: a systemic quantitative review. Brazilian J Infectious Disease, 18, 651-9. https://doi.org/10.1016/j.bjid.2014.02.005
  9. Jain N, Euler GL, Shefer A, et al (2009). Human papillomavirus (HPV) awareness and vaccination among women in the united states, national immunization Survey-Adult 2007. Prev Med, 48, 426-31. https://doi.org/10.1016/j.ypmed.2008.11.010
  10. Lim BK, Ng KY, Omar J, et al (2014). Immunogenicity and Safety of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine in malaysian women aged 18-35 years: a randomized controlled Trial. Med J Malaysia, 69, 1-8.
  11. Othman N, Rebolj M (2009). Challenges to cervical cancer screening in a developing country: the case of Malaysia. Asian Pac J Cancer Prev, 10, 747-52.
  12. Rambout L, Tashkandi M, Hopkins L, et al (2014). Self-reported barriers and facillitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systemic review. Prev Med, 58, 22-32. https://doi.org/10.1016/j.ypmed.2013.10.009
  13. Sam I-C, Path MRC, Wong LP, et al (2009). Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolescent Health, 44, 610-2. https://doi.org/10.1016/j.jadohealth.2008.11.014
  14. Schiffman M, Castle P, Jeronimo J, et al (2007). Human papillomavirus and cervical cancer. Lancet, 370, 890-907. https://doi.org/10.1016/S0140-6736(07)61416-0
  15. Sherris J, Friedman A, Wittet S, et al (2006). Chapter 25: Education, training and communication for HPV vaccines. Vaccines, 24, 210-8. https://doi.org/10.1016/j.vaccine.2006.05.124
  16. Wong LP (2008). Young Multiethnic women’s attitute toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstetrics, 103, 131-5. https://doi.org/10.1016/j.ijgo.2008.07.005
  17. Wong LP (2009). Preventing cervical cancer through human papillomavirus vaccination : prespective from focus group. JLower Genital Tract Disease, 13, 85-93. https://doi.org/10.1097/LGT.0b013e3181865f44
  18. Wong LP (2010). Knowledge and Attitude about HPV infection, HPV vaccination and cervical cancer among rural southeast Asian women. Int Soc Behavioural Med, 18, 105-11.